Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography

Radiology

Volumn 274, Issue 3, 2015, Pages 723-733

  Kim, Seong Ho ^a   Lee, Jeong Min ^a   Lee, Eun Sun ^b   Baek, Jee Hyun ^a   Kim, Jung Hoon ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a  

^a Seoul National University Hospital   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CARCINOMA, PAPILLARY; EVALUATION STUDY; FEMALE; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PANCREAS DUCT; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84924334496     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14132960     Document Type: Article

References (34)

1. Lim JH, Lee G, Oh YL. Radiologic spectrum of intraductal papillary mucinous tumor of the pancreas. RadioGraphics 2001;21(2):323-337; discussion 337-340
2. Augustin T, Vandermeer TJ. Intraductal papillary mucinous neoplasm: A clinicopathologic review. Surg Clin North Am 2010;90(2):377-398
3. Shi C, Hruban RH. Intraductal papillary mucinous neoplasm. Hum Pathol 2012; 43(1):1-16
4. Klibansky DA, Reid-Lombardo KM, Gordon SR, Gardner TB. The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol 2012;10(5):555-558
5. de Jong K, Bruno MJ, Fockens P. Epidemiology, diagnosis, and management of cystic lesions of the pancreas. Gastroenterol Res Pract 2012;2012:147465
6. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28(8):977-987
7. Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12(3):183-197
8. Bassi C, Sarr MG, Lillemoe KD, Reber HA. Natural history of intraductal papillary mucinous neoplasms (IPMN): Current evidence and implications for management. J Gastrointest Surg 2008;12(4):645-650
9. Kimura W, Sasahira N, Yoshikawa T, Muto T, Makuuchi M. Duct-ectatic type of mucin producing tumor of the pancreas: new concept of pancreatic neoplasia. Hepatogastroenterology 1996;43(9):692-709
10. Ogawa H, Itoh S, Ikeda M, Suzuki K, Naganawa S. Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology 2008;248(3):876-886
11. Kawamoto S, Horton KM, Lawler LP, Hruban RH, Fishman EK. Intraductal papillary mucinous neoplasm of the pancreas: Can benign lesions be differentiated from malignant lesions with multidetector CT? RadioGraphics 2005;25(6):1451-1468; discussion 1468-1470
12. Taouli B, Vilgrain V, Vullierme MP, et al. Intraductal papillary mucinous tumors of the pancreas: helical CT with histopathologic correlation. Radiology 2000;217(3):757-764
13. Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas: Imaging studies and treatment strategies. Ann Surg 1998;228(5):685-691
14. Manfredi R, Graziani R, Motton M, et al. Main pancreatic duct intraductal papillary mucinous neoplasms: Accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology 2009;253(1): 106-115
15. Vullierme MP, Giraud-Cohen M, Hammel P, et al. Malignant intraductal papillary mucinous neoplasm of the pancreas: In situ versus invasive carcinoma surgical resectability. Radiology 2007;245(2):483-490
16. Uchiyama S, Chijiiwa K, Hiyoshi M, et al. Mucin-producing bile duct tumor of the caudate lobe protruding into the common hepatic duct. J Gastrointest Surg 2007;11(11): 1570-1572
17. Sugiyama M, Izumisato Y, Abe N, Masaki T, Mori T, Atomi Y. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 2003;90(10):1244-1249
18. Sugiyama M, Atomi Y, Kuroda A. Two types of mucin-producing cystic tumors of the pancreas: Diagnosis and treatment. Surgery 1997;122(3):617-625
19. Waters JA, Schmidt CM, Pinchot JW, et al. CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 2008;12(1):101-109
20. Song SJ, Lee JM, Kim YJ, et al. Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: Comparison of multirow-detector CT and MR imaging using ROC analysis. J Magn Reson Imaging 2007;26(1):86-93
21. Sahani DV, Kadavigere R, Blake M, Fernandez- Del Castillo C, Lauwers GY, Hahn PF. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations-correlation with MRCP. Radiology 2006;238(2):560-569
22. Pedrosa I, Boparai D. Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg 2010;2(10):324-330
23. Macari M, Eubig J, Robinson E, et al. Frequency of intraductal papillary mucinous neoplasm in patients with and without pancreas cancer. Pancreatology 2010;10(6): 734-741
24. Kim JH, Hong SS, Kim YJ, Kim JK, Eun HW. Intraductal papillary mucinous neoplasm of the pancreas: Differentiate from chronic pancreatits by MR imaging. Eur J Radiol 2012;81(4):671-676
25. Kang KM, Lee JM, Shin CI, et al. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. J Magn Reson Imaging 2013;38(3):555-563
26. Gourgiotis S, Ridolfini MP, Germanos S. Intraductal papillary mucinous neoplasms of the pancreas. Eur J Surg Oncol 2007;33(6): 678-684
27. Berland LL, Silverman SG, Gore RM, et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 2010;7(10):754-773
28. Pezzilli R, Serra C, Calculli L, Ferroni F, Iammarino MT, Casadei R. Three-dimensional contrast-enhanced ultrasonography of intraductal papillary mucinous neoplasms of the pancreas: A comparison with magnetic resonance imaging. Pancreas 2013;42(7): 1164-1168
29. Raman SP, Kawamoto S, Blackford A, et al. Histopathologic findings of multifocal pancreatic intraductal papillary mucinous neoplasms on CT. AJR Am J Roentgenol 2013;200(3): 563-569
30. Diehl SJ, Lehmann KJ, Sadick M, Lachmann R, Georgi M. Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 1998;206(2):373-378
31. Hough TJ, Raptopoulos V, Siewert B, Matthews JB. Teardrop superior mesenteric vein: CT sign for unresectable carcinoma of the pancreas. AJR Am J Roentgenol 1999;173(6): 1509-1512
32. O'Malley ME, Boland GW, Wood BJ, Fernandez- del Castillo C, Warshaw AL, Mueller PR. Adenocarcinoma of the head of the pancreas: Determination of surgical unresectability with thin-section pancreatic- phase helical CT. AJR Am J Roentgenol 1999;173(6):1513-1518
33. Verbeke CS. Resection margins in pancreatic cancer. Surg Clin North Am 2013;93(3): 647-662
34. Barron MR, Roch AM, Waters JA, et al. Does preoperative cross-sectional imaging accurately predict main duct involvement in intraductal papillary mucinous neoplasm? J Gastrointest Surg 2014;18(3):447-455; discussion 5455-5456.